Effect of Dapagliflozin on Glycemic Variability
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Dapagliflozin
Related studies linked through entity extraction aliases.
An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin
- Status
- COMPLETED
- Phase
- PHASE4
Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE4
Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell
- Status
- COMPLETED
- Phase
- NA
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content
- Status
- COMPLETED
- Phase
- PHASE3
Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes
- Status
- UNKNOWN
- Phase
- PHASE4
Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?
- Status
- COMPLETED
- Phase
- PHASE2
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy
- Status
- COMPLETED
- Phase
- PHASE4
The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients
- Status
- COMPLETED
- Phase
- PHASE4
Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients
- Status
- COMPLETED
- Phase
- PHASE2
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE4
Dapagliflozin Effects on Epicardial Fat
- Status
- COMPLETED
- Phase
- PHASE4
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
- Status
- COMPLETED
- Phase
- PHASE3
Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State
- Status
- COMPLETED
- Phase
- PHASE1